Research entry

Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study

A summary of the study, its context and what has been checked.

Ask the Adoptee Rights Assistant
Adoptee Rights Assistant

Please leave out names and identifying details.

Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study

Linda Titus, Elizabeth E Hatch, Kimberly A Bertrand, Julie R Palmer, William C Strohsnitter, Dezheng Huo, Michael Curry, Marianne Hyer, Kjersti Aagaard, Gretchen L Gierach, Rebecca Troisi · Cancers

This update examined cancers and benign conditions in offspring of women exposed to DES before birth. It found little evidence of increased overall cancer risk in the third generation so far. Estimates for borderline ovarian cancer and male overall cancer were imprecise, and participants remained relatively young.

Why it matters to adoptees: Helps adoptees and their children distinguish unresolved cancer questions from established prenatal-exposure risks without assuming that harm necessarily continues in every generation.

Limitations: Self-reported and mother-reported outcomes, rare diagnoses and wide confidence intervals limit conclusions. Absence of a clear increase so far is not proof of no later-life risk. Not an adoptee cohort; overlaps with the NCI programme and does not establish effects of post-birth lactation suppression.

Research type
Observational cohort study
Source reviewed
Abstract
Peer reviewed
Yes
Age group
Adults / Offspring across generations
Study context and review

Age group as recorded: Adults; offspring across generations

Adoption context: Medical evidence relevant to adoptees; not an adoptee sample

Programme: NCI DES Follow-up Study

Institutional context: Government / government-commissioned research

US National Cancer Institute collaborative research programme. Public research body; funding/commissioning details require study-specific review.

Scoped bibliographic and source review. Bibliographic relationships are not a bias or safety rating.

Topics: adoptee-relevant medical evidence, cancer, DES, diethylstilbestrol, medical history, multigenerational health

Review scope: PubMed abstract, author/conflict metadata and selected PMC methods/results; not a comprehensive full-text review.

Country as recorded: United States

Funding
PubMed lists NIEHS grant P30 ES027792; full funding statement and funder role not comprehensively reviewed.
Commissioner
Not yet checked
Funder role
Not yet checked
Declared conflicts
Michael Curry and Marianne Hyer employed by Information Management Services; remaining authors declared no conflicts.
Recruitment
Not yet checked for this entry
Adoptee involvement
Not established in material reviewed

Entry: study_a778e3b9db15ae40

Read the source for Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study (opens in a new tab)

Browse all studies · Suggest a correction to this entry